CHHE
China Health Industries Holdings, Inc.Company Information
- Company Name
- China Health Industries Holdings, Inc.
- CIK
- CIK0001309057
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CHHE: OTC
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CHHE
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2024-06-26
- Price on filing date
- —
- 1-month reaction
- -59.27%
- 3-month reaction
- -71.24%
Balance Sheet
Values in millions ($)| Line item | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | 5 | 5 | - | - | - | 7 | - | - | - | - | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 43 | 43 | 42 | 45 | 47 | 47 | 46 | 44 | ||||||
| Accounts Receivable Net Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Supplies | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 41 | 41 | 44 | 44 | 43 | 46 | 49 | 48 | 48 | 48 | ||||||
| Prepaid Insurance | - | - | 40 | 41 | - | - | - | - | - | - | - | - | ||||||
| Advances On Inventory Purchases | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Assets | 4 | 4 | 45 | 45 | 49 | 49 | 48 | 51 | 54 | 54 | 54 | 54 | ||||||
Liabilities And Equity | ||||||||||||||||||
| Short Term Borrowings | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Other Liabilities | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 10 | 9 | 9 | 9 | ||||||
| Other Notes Payable Current | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Customer Advances Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | ||||||
| Due To Related Parties Current | - | - | - | - | - | 6 | 6 | 7 | 7 | 8 | 8 | 8 | ||||||
| Debt Current | - | - | - | - | 6 | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | - | - | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Accrued Salaries Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Stockholders Equity | -2 | -2 | 39 | 39 | 42 | 42 | 40 | 43 | 45 | 45 | 45 | 45 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -3 | -3 | -3 | -1 | -1 | -2 | 1 | 3 | 3 | 2 | 2 | ||||||
| Retained Earnings Accumulated Deficit | 41 | 41 | 41 | 41 | 42 | 42 | 41 | 42 | 41 | 41 | 42 | 42 | ||||||
| Liabilities And Stockholders Equity | 4 | 4 | 45 | 45 | 49 | 49 | 48 | 51 | 54 | 54 | 54 | 54 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | ||||||
| Shares Outstanding | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialChina Health Industries Holdings, Inc. (CHHE) — SEC Financial Statements & Analysis
China Health Industries Holdings, Inc. (CHHE) is a pharmaceutical preparations company. China Health Industries Holdings, Inc. trades on OTC as: CHHE. China Health Industries Holdings, Inc. (CHHE)'s most recent SEC filing is a Form 10-Q for the period ended 2024-03-31, filed with the SEC on 2024-06-26. Based on that filing, China Health Industries Holdings, Inc. carries a market cap of $19.16M, a P/E ratio of -14.07x, a P/B ratio of -7.99x, a P/S ratio of 199.74x, an enterprise value of $19.18M, and an EV/EBITDA multiple of -17.37x. On profitability, it posts a gross margin of -5.06%, an operating margin of -1439.71%, a net margin of -1419.55%, a Return on Equity (ROE) of -6.89%, a Return on Assets (ROA) of -5.18%, and a Return on Invested Capital (ROIC) of -8.44%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $-0.65, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 8.36% year-over-year, net income growth of -293.89% year-over-year, and EPS growth of -293.89% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.04x, working capital of $-6.28M, a debt-to-equity ratio of -2.72x, a debt ratio of 1.58, an interest coverage ratio of -27626.96x, free cash flow of $-42.79M (TTM), and net debt of $16.52K. Figures sourced from SEC EDGAR.
- Market Cap
- $19.16M
- P/E TTM
- -14.07x
- EPS TTM
- $-0.02
- P/B TTM
- -7.99x
- ROE TTM
- -6.89%
- ROA TTM
- -5.18%
- Debt To Equity
- -2.72x
- Free Cash Flow TTM
- $-42.79M
- Net Revenue TTM Growth 1Y
- 8.36%
Data as of 2024-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is China Health Industries Holdings, Inc. in?
China Health Industries Holdings, Inc. (CHHE) operates in the Pharmaceutical Preparations industry.
What exchange does CHHE trade on?
China Health Industries Holdings, Inc. (CHHE) trades on the OTC.
When was China Health Industries Holdings, Inc. (CHHE)'s most recent SEC filing?
China Health Industries Holdings, Inc. (CHHE)'s most recent SEC filing is a Form 10-Q for the period ended 2024-03-31, filed with the SEC on 2024-06-26.
What is CHHE's market cap?
China Health Industries Holdings, Inc. (CHHE) has a market capitalization of $19.16M as of 2024-03-31.
What is CHHE's EPS (earnings per share)?
China Health Industries Holdings, Inc. (CHHE)'s trailing twelve month EPS is $-0.02 as of 2024-03-31.
What is CHHE's ROE (return on equity)?
China Health Industries Holdings, Inc. (CHHE)'s trailing twelve month Return on Equity (ROE) is -6.89% as of 2024-03-31.
What is CHHE's ROA (return on assets)?
China Health Industries Holdings, Inc. (CHHE)'s trailing twelve month Return on Assets (ROA) is -5.18% as of 2024-03-31.
What is CHHE's ROIC (return on invested capital)?
China Health Industries Holdings, Inc. (CHHE)'s trailing twelve month Return on Invested Capital (ROIC) is -8.44% as of 2023-09-30.
What is CHHE's EV/EBITDA?
China Health Industries Holdings, Inc. (CHHE)'s trailing twelve month EV/EBITDA is -17.37x as of 2024-03-31.